Triple S Ventures

Triple S Ventures is a venture capital firm established in 2022 and located in Glendale, California. The firm specializes in investing in pre-seed and seed-stage startups, focusing on various sectors including artificial intelligence, blockchain technologies, the creator economy, SaaS platforms, and fintech. With a commitment to nurturing and scaling innovative technologies, Triple S Ventures emphasizes investments in companies that contribute to core value-added activities in Armenia while also considering opportunities in other regions. Leveraging a global network and extensive expertise, the firm aims to support emerging businesses in their growth journey.

Narine Davtian

Investment Manager

Hakob Hakobyan Ph.D

General Partner

Artur Janibekyan

Founder and General Partner

Avag Simonyan

Managing Partner

7 past transactions

SimCare AI

Seed Round in 2025
SimCare AI is a healthcare technology firm that is using artificial intelligence to revolutionize clinical training.

Optimyzee

Seed Round in 2023
Optimyzee is an AI-powered ad management platform that specializes in streamlining and optimizing Google Ads campaigns for small businesses and freelancers. By automating the processes typically handled by experienced PPC specialists, Optimyzee allows marketing agencies to save time and reduce hiring costs while enhancing their clients' sales outcomes. The platform not only structures ad campaigns effectively but also identifies relevant advertising channels, enabling businesses to establish a robust online presence. This innovative tool provides users with a competitive edge in the digital marketing landscape by maximizing the effectiveness of their advertising budgets.

Cloudchipr

Pre Seed Round in 2023
Cloudchipr is a platform for cloud cost management and analytics for users of multiple cloud accounts. They help companies to cut their cloud bills.

Denovo Sciences

Pre Seed Round in 2023
Denovo Sciences is a drug discovery company that leverages advanced AI technologies to create innovative therapeutics. The company focuses on designing and optimizing chemical structures through computational simulations, which facilitate directed searches within chemical space. Denovo Sciences specializes in drug design and the generation of polypharmacological compounds, aiming to develop novel molecules capable of interacting with unique higher-order RNA structures. This approach enhances the efficiency and effectiveness of the drug design process for medical professionals.

Docus

Pre Seed Round in 2023
Docus is an AI-driven health platform that facilitates global connections between hospitals and doctors. The platform provides a comprehensive suite of services including telemedicine capabilities, video and chat communication, electronic health records, and appointment scheduling. Patients can interact with AI health assistants to generate personalized health reports, which can then be validated by top doctors from the United States and Europe. This integration of technology aims to enhance patient care by streamlining communication and improving access to medical expertise.

SleepDoctor

Pre Seed Round in 2022
SleepDoctor is a digital sleep clinic that operates a teleconsultation and diagnosis platform designed to connect patients with sleep specialists worldwide. The platform offers specialized programs focused on various sleep disorders, aiming to be a comprehensive resource for individuals seeking to address their sleep-related issues. By providing easy and efficient tools, SleepDoctor helps users holistically improve their sleep, potentially preventing serious health problems such as stroke, heart attack, and diabetes.

Modicus Prime

Pre Seed Round in 2022
Modicus Prime specializes in developing advanced computer vision software and self-service artificial intelligence tools tailored for the life sciences sector. Their technology automates the analysis of biologics images, addressing challenges related to product quality failures that can result in significant costs, legal issues, and waste in research and manufacturing processes. The platform facilitates the integration of diverse life sciences data, enabling users to detect anomalies, monitor operations, and enhance decision-making. By allowing clients to execute cutting-edge research and production, train algorithms on specific data sets, and harness insights through self-service capabilities, Modicus Prime effectively addresses the evolving data challenges in the life sciences industry, including continuous manufacturing and intelligent monitoring.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.